The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC
Videos  >  

Treatments on the Horizon in NETs

Matthew Kulke, MD
Published Online:2:24 PM, Wed November 1, 2017

Matthew Kulke, MD, director, Neuroendocrine and Carcinoid Tumors Program, Dana-Farber Cancer Institute, discusses treatment options on the horizon in the treatment of neuroendocrine tumors (NETs) during the 2017 NANETS Symposium.
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.